Prestige Consumer Healthcare, Inc. (PBH)
50.62
+2.40
(+4.98%)
USD |
NYSE |
Nov 18, 16:00
50.62
0.00 (0.00%)
After-Hours: 20:00
Prestige Consumer Healthcare Price to Book Value : 1.234 for Nov. 18, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 17, 2026 | 1.175 |
| November 16, 2026 | 1.170 |
| November 13, 2026 | 1.126 |
| November 12, 2026 | 1.105 |
| November 11, 2026 | 1.076 |
| November 10, 2026 | 1.096 |
| November 09, 2026 | 1.064 |
| November 06, 2026 | 1.048 |
| November 05, 2026 | 1.080 |
| November 04, 2026 | 1.299 |
| November 03, 2026 | 1.207 |
| November 02, 2026 | 1.212 |
| October 30, 2026 | 1.196 |
| October 29, 2026 | 1.188 |
| October 28, 2026 | 1.165 |
| October 27, 2026 | 1.155 |
| October 26, 2026 | 1.174 |
| October 23, 2026 | 1.165 |
| October 22, 2026 | 1.206 |
| October 21, 2026 | 1.168 |
| October 20, 2026 | 1.203 |
| October 19, 2026 | 1.212 |
| October 16, 2026 | 1.217 |
| October 15, 2026 | 1.199 |
| October 14, 2026 | 1.180 |
| Date | Value |
|---|---|
| October 13, 2026 | 1.182 |
| October 12, 2026 | 1.194 |
| October 09, 2026 | 1.176 |
| October 08, 2026 | 1.167 |
| October 07, 2026 | 1.159 |
| October 06, 2026 | 1.132 |
| October 05, 2026 | 1.111 |
| October 02, 2026 | 1.103 |
| October 01, 2026 | 1.091 |
| September 30, 2026 | 1.118 |
| September 29, 2026 | 1.155 |
| September 28, 2026 | 1.160 |
| September 25, 2026 | 1.152 |
| September 24, 2026 | 1.128 |
| September 23, 2026 | 1.135 |
| September 22, 2026 | 1.180 |
| September 21, 2026 | 1.157 |
| September 18, 2026 | 1.111 |
| September 17, 2026 | 1.148 |
| September 16, 2026 | 1.158 |
| September 15, 2026 | 1.154 |
| September 14, 2026 | 1.177 |
| September 11, 2026 | 1.160 |
| September 10, 2026 | 1.17 |
| September 09, 2026 | 1.204 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Supernus Pharmaceuticals, Inc. | 1.589 |
| Phibro Animal Health Corp. | 3.460 |
| Structure Therapeutics, Inc. | 1.014 |
| ANI Pharmaceuticals, Inc. | 2.497 |
| Corcept Therapeutics, Inc. | 8.883 |
Price to Book Value Related Metrics
| PE Ratio | 15.59 |
| PS Ratio | 2.071 |
| Price to Free Cash Flow | 11.28 |
| Price | 50.62 |
| Earnings Yield | 6.41% |
| Market Cap | 2.399B |
| Operating PE Ratio | 8.299 |
| Normalized PE Ratio | 15.50 |